Your session is about to expire
← Back to Search
Diagnostic Test
Veriton SPECT/CT for Gamma Camera Comparison
N/A
Recruiting
Led By Carrie Hruska, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial will test a new gamma camera to see if it is more sensitive and produces better images than a standard camera.
Who is the study for?
This trial is for adults over 18 who are already scheduled for a nuclear medicine exam. Participants must be able to lie on the Veriton imaging table for up to 40 minutes and provide informed consent. It's not open to those under 18 or anyone unable to comply with these requirements.Check my eligibility
What is being tested?
The study is testing the Veriton SPECT/CT system, a new type of gamma camera designed for nuclear medicine exams. It aims to see if it can produce better images with higher sensitivity compared to conventional cameras while maintaining or improving image quality.See study design
What are the potential side effects?
Since this trial involves imaging technology rather than medication, traditional side effects aren't expected. However, there may be discomfort from lying still on the imaging table during the procedure.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Image quality
Trial Design
1Treatment groups
Experimental Treatment
Group I: Evaluation of the Veriton SPECT/CT systemExperimental Treatment1 Intervention
To determine if the Veriton system can achieve equal or better image quality than a standard SPECT/CT system.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,211 Previous Clinical Trials
3,766,698 Total Patients Enrolled
Carrie Hruska, PhDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
1,757 Total Patients Enrolled
Michael K O'Connor, PhDPrincipal InvestigatorMayo Clinic
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You cannot lie down on a Veriton imaging table for a maximum of 40 minutes.
Research Study Groups:
This trial has the following groups:- Group 1: Evaluation of the Veriton SPECT/CT system
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are engaged in this research experiment?
"Affirmative, the information from clinicaltrials.gov indicates that this trial is currently recruiting participants. The study's inception was on January 20th 2021 and it has since been updated as recently as January 25th 2022. A total of 270 people are needed at one medical site to complete the research."
Answered by AI
What is the current availability for potential participants in this research?
"Per clinicaltrials.gov, this medical trial is actively seeking out suitable volunteers and has been since the 1st of January 2021; it was last modified on 25th January 2022."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger